Reply to “A Word of Caution in Considering the Use of the Lipoarabinomannan Lateral Flow Assay on Cerebrospinal Fluid for Detection of Tuberculous Meningitis”
Year: 2015
Type: letter
Abstract: In their [letter][1], Bahr and colleagues report their inability to detect lipoarabinomannan (LAM) in the cerebrospinal fluid (CSF) of patients with tuberculous meningitis (TBM) by using a lateral flow assay (Determine TB LAM; Alere, Waltham, MA, USA). Several studies have shown LAM positivity in
Source: Journal of Clinical Microbiology
DOI: 10.1128/jcm.02823-15
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2198455991
